United States Biotechnology & Medical Research

Bicara Therapeutics Inc (BCAX)

Track

Bicara Therapeutics Inc. experienced twenty-nine insider trading transactions over the past ninety days, totaling approximately 11.9 million dollars in sales. Key executives, including the CEO and CFO, executed these planned or proposed divestments. This activity follows a recent earnings report that missed expectations, while the stock price has risen 25.9 percent during this period.
Ticker: BCAX Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Bicara Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Hyep Ivan Chief Financial Officer Officer
Transaction date
Planned sale
Price
327.78
Quantity 89,237 +19.4%
Value US$420,250
Cohlhepp Ryan President and COO Executive Director
Transaction date
Planned sale
Price
433.90
Quantity 42,710 +49.4%
Value US$2,230,471
Mazumdar Claire Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
36.96
Quantity 33,097 +5.5%
Value US$2,399,302
Hyep Ivan Officer Officer
Transaction date
Proposed sale
Price
27.83
Quantity 1,000
Value US$100,000
Cohlhepp Ryan Officer; Director Executive Director
Transaction date
Proposed sale
Price
27.83
Quantity 1,000
Value US$100,000
Mazumdar Claire Officer; Director Executive Director
Transaction date
Proposed sale
Price
27.83
Quantity 1,000
Value US$100,000
Mazumdar Claire Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
29.68
Quantity 28 -0.0%
Value US$831
Mazumdar Claire Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
28.42
Quantity 9,972 -2.7%
Value US$283,367
Mazumdar Claire Officer; Director Executive Director
Transaction date
Proposed sale
Price
29.68
Quantity 10,000
Value US$296,800
Cohlhepp Ryan President and COO Executive Director
Transaction date
Planned sale
Price
29.00
Quantity 536 -0.3%
Value US$15,544
Cohlhepp Ryan President and COO Executive Director
Transaction date
Planned sale
Price
30.35
Quantity 1,075 -0.6%
Value US$32,632
Cohlhepp Ryan President and COO Executive Director
Transaction date
Planned sale
Price
29.80
Quantity 4,306 -2.3%
Value US$128,302
Cohlhepp Ryan President and COO Executive Director
Transaction date
Planned sale
Price
28.76
Quantity 22,833 -10.9%
Value US$656,652
Hyep Ivan Chief Financial Officer Officer
Transaction date
Planned sale
Price
30.31
Quantity 830 -0.6%
Value US$25,160
Hyep Ivan Chief Financial Officer Officer
Transaction date
Planned sale
Price
29.82
Quantity 4,413 -3.3%
Value US$131,616
Hyep Ivan Chief Financial Officer Officer
Transaction date
Planned sale
Price
28.60
Quantity 22,757 -14.4%
Value US$650,896
DAVID RABEN Officer Officer
Transaction date
Proposed sale
Price
28.56
Quantity 50,000
Value US$1,428,080
Cohlhepp Ryan Officer; Director Executive Director
Transaction date
Proposed sale
Price
30.25
Quantity 28,750
Value US$869,688
Hyep Ivan Officer Officer
Transaction date
Proposed sale
Price
30.25
Quantity 28,000
Value US$847,000
3.5
Lara Meisner Officer Officer
Transaction date
Proposed sale
Price
29.77
Quantity 1,000
Value US$29,774
DAVID RABEN Officer Officer
Transaction date
Proposed sale
Price
26.49
Quantity 50,000
Value US$1,324,650
3.5
Meisner Lara Former Chief Legal Officer Officer
Transaction date
Proposed sale
Price
20.64
Quantity 71,390
Value US$1,473,716
Raben David Officer Officer
Transaction date
Proposed sale
Price
21.82
Quantity 5,500
Value US$120,010
Hyep Ivan Chief Financial Officer Officer
Transaction date
Planned sale
Price
20.42
Quantity 9,200 -6.0%
Value US$187,883
Hyep Ivan Officer Officer
Transaction date
Proposed sale
Price
20.42
Quantity 9,200
Value US$187,883
Mazumdar Claire Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
20.35
Quantity 2,978 -0.8%
Value US$60,597
Mazumdar Claire Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
19.96
Quantity 12,022 -3.2%
Value US$239,982
Mazumdar Claire Officer; Director Executive Director
Transaction date
Proposed sale
Price
20.92
Quantity 15,000
Value US$313,800
Mazumdar Claire Officer; Director Executive Director
Transaction date
Proposed sale
Price
20.92
Quantity 15,000
Value US$313,800
Cohlhepp Ryan President and COO Executive Director
Transaction date
Planned sale
Price
20.29
Quantity 4,500 -2.3%
Value US$91,314
Cohlhepp Ryan President and COO Executive Director
Transaction date
Planned sale
Price
20.29
Quantity 8,000 -3.9%
Value US$162,335
Cohlhepp Ryan Officer; Director Executive Director
Transaction date
Proposed sale
Price
20.31
Quantity 12,500
Value US$253,875
Raben David Chief Medical Officer Officer
Transaction date
Planned sale
Price
22.88
Quantity 5,500 -9.0%
Value US$125,830
Raben David Officer Officer
Transaction date
Proposed sale
Price
22.88
Quantity 5,500
Value US$125,830
Hyep Ivan Chief Financial Officer Officer
Transaction date
Planned sale
Price
23.00
Quantity 9,200 -6.0%
Value US$211,614
Hyep Ivan Officer Officer
Transaction date
Proposed sale
Price
23.18
Quantity 9,200
Value US$213,210
Mazumdar Claire Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
23.61
Quantity 15,000 -4.0%
Value US$354,146
Mazumdar Claire Officer; Director Executive Director
Transaction date
Proposed sale
Price
23.74
Quantity 15,000
Value US$356,100
Cohlhepp Ryan President and COO Executive Director
Transaction date
Planned sale
Price
23.01
Quantity 4,500 -2.2%
Value US$103,533
Cohlhepp Ryan President and COO Executive Director
Transaction date
Planned sale
Price
23.01
Quantity 8,000 -3.8%
Value US$184,058
Cohlhepp Ryan Officer; Director Executive Director
Transaction date
Proposed sale
Price
22.98
Quantity 12,500
Value US$287,250
Raben David Chief Medical Officer Officer
Transaction date
Planned sale
Price
18.95
Quantity 5,500 -9.0%
Value US$104,229
Raben David Officer Officer
Transaction date
Proposed sale
Price
18.95
Quantity 5,500
Value US$104,229
Hyep Ivan Chief Financial Officer Officer
Transaction date
Planned sale
Price
18.52
Quantity 9,200 -6.0%
Value US$170,348
Hyep Ivan Officer Officer
Transaction date
Proposed sale
Price
18.60
Quantity 9,200
Value US$171,120
Mazumdar Claire Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
18.95
Quantity 1,596 -0.5%
Value US$30,246
Mazumdar Claire Officer; Director Executive Director
Transaction date
Proposed sale
Price
18.95
Quantity 1,596
Value US$30,246
Mazumdar Claire Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
18.78
Quantity 6,905 -2.0%
Value US$129,705
Mazumdar Claire Officer; Director Executive Director
Transaction date
Proposed sale
Price
18.78
Quantity 6,905
Value US$129,705
Mazumdar Claire Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
18.84
Quantity 6,499 -1.9%
Value US$122,415
Mazumdar Claire Officer; Director Executive Director
Transaction date
Proposed sale
Price
19.19
Quantity 6,499
Value US$124,716
Cohlhepp Ryan President and COO Executive Director
Transaction date
Planned sale
Price
19.66
Quantity 4,500 -2.2%
Value US$88,457
Cohlhepp Ryan President and COO Executive Director
Transaction date
Planned sale
Price
19.66
Quantity 8,000 -3.8%
Value US$157,257
Cohlhepp Ryan Officer; Director Executive Director
Transaction date
Proposed sale
Price
19.34
Quantity 12,500
Value US$241,750
Mazumdar Claire Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
19.17
Quantity 36,766 -9.8%
Value US$704,657
Mazumdar Claire Officer Officer
Transaction date
Proposed sale
Price
19.17
Quantity 36,766
Value US$704,657
Mazumdar Claire Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
18.75
Quantity 3,817 -1.1%
Value US$71,572
Mazumdar Claire Officer Officer
Transaction date
Proposed sale
Price
19.80
Quantity 3,817
Value US$75,572
Mazumdar Claire Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
18.74
Quantity 1,786 -0.5%
Value US$33,464
Mazumdar Claire Officer Officer
Transaction date
Proposed sale
Price
18.74
Quantity 1,786
Value US$33,464
Mazumdar Claire Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
18.73
Quantity 2,631 -0.8%
Value US$49,289
Hyep Ivan Chief Financial Officer Officer
Transaction date
Planned sale
Price
18.25
Quantity 2,963 -2.0%
Value US$54,062
Raben David Chief Medical Officer Officer
Transaction date
Planned sale
Price
18.52
Quantity 16,300 -22.8%
Value US$301,920
Hyep Ivan Officer Officer
Transaction date
Proposed sale
Price
18.25
Quantity 2,963
Value US$54,062
Mazumdar Claire Officer Officer
Transaction date
Proposed sale
Price
18.73
Quantity 2,631
Value US$49,289
Raben David Officer Officer
Transaction date
Proposed sale
Price
18.52
Quantity 16,300
Value US$301,920
Cohlhepp Ryan President and COO Executive Director
Transaction date
Planned sale
Price
18.16
Quantity 4,500 -2.1%
Value US$81,734
Cohlhepp Ryan President and COO Executive Director
Transaction date
Planned sale
Price
18.16
Quantity 12,892 -5.8%
Value US$234,159
Hyep Ivan Chief Financial Officer Officer
Transaction date
Planned sale
Price
18.22
Quantity 13,555 -8.5%
Value US$246,910
Raben David Chief Medical Officer Officer
Transaction date
Planned sale
Price
18.45
Quantity 200 -0.4%
Value US$3,690
Hyep Ivan Officer Officer
Transaction date
Proposed sale
Price
18.22
Quantity 13,555
Value US$246,910
Raben David Officer Officer
Transaction date
Proposed sale
Price
18.45
Quantity 200
Value US$3,690
Cohlhepp Ryan Officer Officer
Transaction date
Proposed sale
Price
18.16
Quantity 17,392
Value US$315,893
2.9
RA CAPITAL MANAGEMENT, L.P. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
16.00
Quantity 300,000 +7.0%
Value US$4,800,000
Cohlhepp Ryan President and COO Executive Director
Transaction date
Planned sale
Price
18.04
Quantity 523 -0.2%
Value US$9,435
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-12 2026-08-10 PlS Planned sale
Hyep Ivan

Chief Financial Officer

Officer
89,237 +19.4%
327.78
US$420,250 		89,237 +19.4% 327.78 US$420,250
2026-08-12 2026-08-10 PlS Planned sale
Cohlhepp Ryan

President and COO

Executive Director
42,710 +49.4%
433.90
US$2,230,471 		42,710 +49.4% 433.90 US$2,230,471
2026-08-12 2026-08-10 PlS Planned sale
Mazumdar Claire

Chief Executive Officer

Executive Director
33,097 +5.5%
36.96
US$2,399,302 		33,097 +5.5% 36.96 US$2,399,302
2026-08-10 2026-08-10 PrS Proposed sale
Hyep Ivan

Officer

Officer
1,000
27.83
US$100,000 		1,000 27.83 US$100,000
2026-08-10 2026-08-10 PrS Proposed sale
Cohlhepp Ryan

Officer; Director

Executive Director
1,000
27.83
US$100,000 		1,000 27.83 US$100,000
2026-08-10 2026-08-10 PrS Proposed sale
Mazumdar Claire

Officer; Director

Executive Director
1,000
27.83
US$100,000 		1,000 27.83 US$100,000
2026-07-14 2026-07-10 PlS Planned sale
Mazumdar Claire

Chief Executive Officer

Executive Director
28 -0.0%
29.68
US$831 		28 -0.0% 29.68 US$831
2026-07-14 2026-07-10 PlS Planned sale
Mazumdar Claire

Chief Executive Officer

Executive Director
9,972 -2.7%
28.42
US$283,367 		9,972 -2.7% 28.42 US$283,367
2026-07-10 2026-07-10 PrS Proposed sale
Mazumdar Claire

Officer; Director

Executive Director
10,000
29.68
US$296,800 		10,000 29.68 US$296,800
2026-07-10 2026-07-09 PlS Planned sale
Cohlhepp Ryan

President and COO

Executive Director
536 -0.3%
29.00
US$15,544 		536 -0.3% 29.00 US$15,544
2026-07-10 2026-07-08 PlS Planned sale
Cohlhepp Ryan

President and COO

Executive Director
1,075 -0.6%
30.35
US$32,632 		1,075 -0.6% 30.35 US$32,632
2026-07-10 2026-07-08 PlS Planned sale
Cohlhepp Ryan

President and COO

Executive Director
4,306 -2.3%
29.80
US$128,302 		4,306 -2.3% 29.80 US$128,302
2026-07-10 2026-07-08 PlS Planned sale
Cohlhepp Ryan

President and COO

Executive Director
22,833 -10.9%
28.76
US$656,652 		22,833 -10.9% 28.76 US$656,652
2026-07-10 2026-07-08 PlS Planned sale
Hyep Ivan

Chief Financial Officer

Officer
830 -0.6%
30.31
US$25,160 		830 -0.6% 30.31 US$25,160
2026-07-10 2026-07-08 PlS Planned sale
Hyep Ivan

Chief Financial Officer

Officer
4,413 -3.3%
29.82
US$131,616 		4,413 -3.3% 29.82 US$131,616
2026-07-10 2026-07-08 PlS Planned sale
Hyep Ivan

Chief Financial Officer

Officer
22,757 -14.4%
28.60
US$650,896 		22,757 -14.4% 28.60 US$650,896
2026-07-08 2026-07-08 PrS Proposed sale
DAVID RABEN

Officer

Officer
50,000
28.56
US$1,428,080 		50,000 28.56 US$1,428,080
2026-07-08 2026-07-08 PrS Proposed sale
Cohlhepp Ryan

Officer; Director

Executive Director
28,750
30.25
US$869,688 		28,750 30.25 US$869,688
2026-07-08 2026-07-08 PrS Proposed sale
Hyep Ivan

Officer

Officer
28,000
30.25
US$847,000 		28,000 30.25 US$847,000
2026-07-07 2026-07-07 PrS Proposed sale
3.5
Lara Meisner

Officer

Officer
1,000
29.77
US$29,774 		1,000 29.77 US$29,774
2026-06-25 2026-06-25 PrS Proposed sale
DAVID RABEN

Officer

Officer
50,000
26.49
US$1,324,650 		50,000 26.49 US$1,324,650
2026-06-01 2026-06-01 PrS Proposed sale
3.5
Meisner Lara

Former Chief Legal Officer

Officer
71,390
20.64
US$1,473,716 		71,390 20.64 US$1,473,716
2026-05-26 2026-05-26 PrS Proposed sale
Raben David

Officer

Officer
5,500
21.82
US$120,010 		5,500 21.82 US$120,010
2026-05-26 2026-05-21 PlS Planned sale
Hyep Ivan

Chief Financial Officer

Officer
9,200 -6.0%
20.42
US$187,883 		9,200 -6.0% 20.42 US$187,883
2026-05-21 2026-05-21 PrS Proposed sale
Hyep Ivan

Officer

Officer
9,200
20.42
US$187,883 		9,200 20.42 US$187,883
2026-05-20 2026-05-18 PlS Planned sale
Mazumdar Claire

Chief Executive Officer

Executive Director
2,978 -0.8%
20.35
US$60,597 		2,978 -0.8% 20.35 US$60,597
2026-05-20 2026-05-18 PlS Planned sale
Mazumdar Claire

Chief Executive Officer

Executive Director
12,022 -3.2%
19.96
US$239,982 		12,022 -3.2% 19.96 US$239,982
2026-05-18 2026-05-18 PrS Proposed sale
Mazumdar Claire

Officer; Director

Executive Director
15,000
20.92
US$313,800 		15,000 20.92 US$313,800
2026-05-18 2026-05-18 PrS Proposed sale
Mazumdar Claire

Officer; Director

Executive Director
15,000
20.92
US$313,800 		15,000 20.92 US$313,800
2026-05-18 2026-05-15 PlS Planned sale
Cohlhepp Ryan

President and COO

Executive Director
4,500 -2.3%
20.29
US$91,314 		4,500 -2.3% 20.29 US$91,314
2026-05-18 2026-05-15 PlS Planned sale
Cohlhepp Ryan

President and COO

Executive Director
8,000 -3.9%
20.29
US$162,335 		8,000 -3.9% 20.29 US$162,335
2026-05-15 2026-05-15 PrS Proposed sale
Cohlhepp Ryan

Officer; Director

Executive Director
12,500
20.31
US$253,875 		12,500 20.31 US$253,875
2026-04-28 2026-04-27 PlS Planned sale
Raben David

Chief Medical Officer

Officer
5,500 -9.0%
22.88
US$125,830 		5,500 -9.0% 22.88 US$125,830
2026-04-27 2026-04-27 PrS Proposed sale
Raben David

Officer

Officer
5,500
22.88
US$125,830 		5,500 22.88 US$125,830
2026-04-22 2026-04-21 PlS Planned sale
Hyep Ivan

Chief Financial Officer

Officer
9,200 -6.0%
23.00
US$211,614 		9,200 -6.0% 23.00 US$211,614
2026-04-21 2026-04-21 PrS Proposed sale
Hyep Ivan

Officer

Officer
9,200
23.18
US$213,210 		9,200 23.18 US$213,210
2026-04-20 2026-04-20 PlS Planned sale
Mazumdar Claire

Chief Executive Officer

Executive Director
15,000 -4.0%
23.61
US$354,146 		15,000 -4.0% 23.61 US$354,146
2026-04-20 2026-04-20 PrS Proposed sale
Mazumdar Claire

Officer; Director

Executive Director
15,000
23.74
US$356,100 		15,000 23.74 US$356,100
2026-04-17 2026-04-15 PlS Planned sale
Cohlhepp Ryan

President and COO

Executive Director
4,500 -2.2%
23.01
US$103,533 		4,500 -2.2% 23.01 US$103,533
2026-04-17 2026-04-15 PlS Planned sale
Cohlhepp Ryan

President and COO

Executive Director
8,000 -3.8%
23.01
US$184,058 		8,000 -3.8% 23.01 US$184,058
2026-04-15 2026-04-15 PrS Proposed sale
Cohlhepp Ryan

Officer; Director

Executive Director
12,500
22.98
US$287,250 		12,500 22.98 US$287,250
2026-03-26 2026-03-25 PlS Planned sale
Raben David

Chief Medical Officer

Officer
5,500 -9.0%
18.95
US$104,229 		5,500 -9.0% 18.95 US$104,229
2026-03-25 2026-03-25 PrS Proposed sale
Raben David

Officer

Officer
5,500
18.95
US$104,229 		5,500 18.95 US$104,229
2026-03-24 2026-03-23 PlS Planned sale
Hyep Ivan

Chief Financial Officer

Officer
9,200 -6.0%
18.52
US$170,348 		9,200 -6.0% 18.52 US$170,348
2026-03-23 2026-03-23 PrS Proposed sale
Hyep Ivan

Officer

Officer
9,200
18.60
US$171,120 		9,200 18.60 US$171,120
2026-03-20 2026-03-20 PlS Planned sale
Mazumdar Claire

Chief Executive Officer

Executive Director
1,596 -0.5%
18.95
US$30,246 		1,596 -0.5% 18.95 US$30,246
2026-03-20 2026-03-20 PrS Proposed sale
Mazumdar Claire

Officer; Director

Executive Director
1,596
18.95
US$30,246 		1,596 18.95 US$30,246
2026-03-20 2026-03-19 PlS Planned sale
Mazumdar Claire

Chief Executive Officer

Executive Director
6,905 -2.0%
18.78
US$129,705 		6,905 -2.0% 18.78 US$129,705
2026-03-19 2026-03-19 PrS Proposed sale
Mazumdar Claire

Officer; Director

Executive Director
6,905
18.78
US$129,705 		6,905 18.78 US$129,705
2026-03-20 2026-03-18 PlS Planned sale
Mazumdar Claire

Chief Executive Officer

Executive Director
6,499 -1.9%
18.84
US$122,415 		6,499 -1.9% 18.84 US$122,415
2026-03-18 2026-03-18 PrS Proposed sale
Mazumdar Claire

Officer; Director

Executive Director
6,499
19.19
US$124,716 		6,499 19.19 US$124,716
2026-03-17 2026-03-16 PlS Planned sale
Cohlhepp Ryan

President and COO

Executive Director
4,500 -2.2%
19.66
US$88,457 		4,500 -2.2% 19.66 US$88,457
2026-03-17 2026-03-16 PlS Planned sale
Cohlhepp Ryan

President and COO

Executive Director
8,000 -3.8%
19.66
US$157,257 		8,000 -3.8% 19.66 US$157,257
2026-03-16 2026-03-16 PrS Proposed sale
Cohlhepp Ryan

Officer; Director

Executive Director
12,500
19.34
US$241,750 		12,500 19.34 US$241,750
2026-03-11 2026-03-09 PlS Planned sale
Mazumdar Claire

Chief Executive Officer

Executive Director
36,766 -9.8%
19.17
US$704,657 		36,766 -9.8% 19.17 US$704,657
2026-03-09 2026-03-09 PrS Proposed sale
Mazumdar Claire

Officer

Officer
36,766
19.17
US$704,657 		36,766 19.17 US$704,657
2026-03-06 2026-03-06 PlS Planned sale
Mazumdar Claire

Chief Executive Officer

Executive Director
3,817 -1.1%
18.75
US$71,572 		3,817 -1.1% 18.75 US$71,572
2026-03-06 2026-03-06 PrS Proposed sale
Mazumdar Claire

Officer

Officer
3,817
19.80
US$75,572 		3,817 19.80 US$75,572
2026-03-06 2026-03-05 PlS Planned sale
Mazumdar Claire

Chief Executive Officer

Executive Director
1,786 -0.5%
18.74
US$33,464 		1,786 -0.5% 18.74 US$33,464
2026-03-05 2026-03-05 PrS Proposed sale
Mazumdar Claire

Officer

Officer
1,786
18.74
US$33,464 		1,786 18.74 US$33,464
2026-03-06 2026-03-04 PlS Planned sale
Mazumdar Claire

Chief Executive Officer

Executive Director
2,631 -0.8%
18.73
US$49,289 		2,631 -0.8% 18.73 US$49,289
2026-03-05 2026-03-04 PlS Planned sale
Hyep Ivan

Chief Financial Officer

Officer
2,963 -2.0%
18.25
US$54,062 		2,963 -2.0% 18.25 US$54,062
2026-03-05 2026-03-04 PlS Planned sale
Raben David

Chief Medical Officer

Officer
16,300 -22.8%
18.52
US$301,920 		16,300 -22.8% 18.52 US$301,920
2026-03-04 2026-03-04 PrS Proposed sale
Hyep Ivan

Officer

Officer
2,963
18.25
US$54,062 		2,963 18.25 US$54,062
2026-03-04 2026-03-04 PrS Proposed sale
Mazumdar Claire

Officer

Officer
2,631
18.73
US$49,289 		2,631 18.73 US$49,289
2026-03-04 2026-03-04 PrS Proposed sale
Raben David

Officer

Officer
16,300
18.52
US$301,920 		16,300 18.52 US$301,920
2026-03-05 2026-03-03 PlS Planned sale
Cohlhepp Ryan

President and COO

Executive Director
4,500 -2.1%
18.16
US$81,734 		4,500 -2.1% 18.16 US$81,734
2026-03-05 2026-03-03 PlS Planned sale
Cohlhepp Ryan

President and COO

Executive Director
12,892 -5.8%
18.16
US$234,159 		12,892 -5.8% 18.16 US$234,159
2026-03-05 2026-03-03 PlS Planned sale
Hyep Ivan

Chief Financial Officer

Officer
13,555 -8.5%
18.22
US$246,910 		13,555 -8.5% 18.22 US$246,910
2026-03-05 2026-03-03 PlS Planned sale
Raben David

Chief Medical Officer

Officer
200 -0.4%
18.45
US$3,690 		200 -0.4% 18.45 US$3,690
2026-03-03 2026-03-03 PrS Proposed sale
Hyep Ivan

Officer

Officer
13,555
18.22
US$246,910 		13,555 18.22 US$246,910
2026-03-03 2026-03-03 PrS Proposed sale
Raben David

Officer

Officer
200
18.45
US$3,690 		200 18.45 US$3,690
2026-03-03 2026-03-03 PrS Proposed sale
Cohlhepp Ryan

Officer

Officer
17,392
18.16
US$315,893 		17,392 18.16 US$315,893
2026-03-02 2026-02-26 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
300,000 +7.0%
16.00
US$4,800,000 		300,000 +7.0% 16.00 US$4,800,000
2026-02-27 2026-02-25 PlS Planned sale
Cohlhepp Ryan

President and COO

Executive Director
523 -0.2%
18.04
US$9,435 		523 -0.2% 18.04 US$9,435
Explore more

More insider trading research around Bicara Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America